Sugentech Inc. (KOSDAQ:253840)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,720.00
+70.00 (1.24%)
Apr 29, 2026, 2:20 PM KST
2.33%
Market Cap 86.39B
Revenue (ttm) 9.42B
Net Income (ttm) -23.31B
Shares Out 15.29M
EPS (ttm) -1,525.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 479,641
Average Volume 2,722,546
Open 5,640.00
Previous Close 5,650.00
Day's Range 5,600.00 - 5,940.00
52-Week Range 4,310.00 - 9,390.00
Beta 0.55
RSI 56.24
Earnings Date May 14, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 144
Stock Exchange KOSDAQ
Ticker Symbol 253840
Full Company Profile

Financial Performance

In 2025, Sugentech's revenue was 9.42 billion, a decrease of -6.74% compared to the previous year's 10.10 billion. Losses were -23.31 billion, 53.5% more than in 2024.

Financial Statements

News

There is no news available yet.